Cargando…
The relationship between hope, medical expenditure and survival among advanced cancer patients
INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242009/ https://www.ncbi.nlm.nih.gov/pubmed/37287770 http://dx.doi.org/10.3389/fpsyg.2023.1151976 |
_version_ | 1785054116390633472 |
---|---|
author | Chay, Junxing Huynh, Vinh Anh Cheung, Yin Bun Kanesvaran, Ravindran Lee, Lai Heng Malhotra, Chetna Finkelstein, Eric Andrew |
author_facet | Chay, Junxing Huynh, Vinh Anh Cheung, Yin Bun Kanesvaran, Ravindran Lee, Lai Heng Malhotra, Chetna Finkelstein, Eric Andrew |
author_sort | Chay, Junxing |
collection | PubMed |
description | INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test these hypotheses among patients with advanced cancer. METHODS: A secondary data analysis from a cross-sectional survey of 195 advanced cancer patients with high mortality risk linked to subsequent healthcare utilization (outpatient, day surgeries, non-emergency admissions), health expenditures, and death records. The survey collected data on hope, measured generally by the Herth Hope Index (HHI) and more narrowly by two questions on illness-related hope. Generalized linear regression and Cox models were used to test our hypotheses. RESULTS: 142 (78%) survey participants died during the period of analysis, with close to half (46%) doing so within a year of the survey. Contrary to expectation, HHI scores did not have a significant association with healthcare utilization, expenditure or survival. Yet, illness-related hope, defined as those who expected to live at least 2 years, as opposed to the likely prognosis of 1 year or less as determined by the primary treating oncologist, had 6.6 more planned hospital encounters (95% CI 0.90 to 12.30) in the 12-months following the survey and 41% lower mortality risk (hazard ratio: 0.59, 95% CI 0.36 to 0.99) compared to those who were less optimistic. Secondary analysis among decedents showed that patients who believed that the primary intent of their treatment is curative, had higher total expenditure (S$30,712; 95% CI S$3,143 to S$58,282) in the last 12 months of life than those who did not have this belief. CONCLUSION: We find no evidence of a relationship between a general measure of hope and healthcare utilization, expenditure, or survival among advanced cancer patients. However, greater illness-related hope is positively associated with these outcomes. |
format | Online Article Text |
id | pubmed-10242009 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102420092023-06-07 The relationship between hope, medical expenditure and survival among advanced cancer patients Chay, Junxing Huynh, Vinh Anh Cheung, Yin Bun Kanesvaran, Ravindran Lee, Lai Heng Malhotra, Chetna Finkelstein, Eric Andrew Front Psychol Psychology INTRODUCTION: Among those with advanced illness, higher levels of hope may offer physiological benefits. Yet, greater levels of hope may also encourage aggressive treatments. Therefore, higher levels of hope may lead to greater healthcare utilization, higher expenditure, and longer survival. We test these hypotheses among patients with advanced cancer. METHODS: A secondary data analysis from a cross-sectional survey of 195 advanced cancer patients with high mortality risk linked to subsequent healthcare utilization (outpatient, day surgeries, non-emergency admissions), health expenditures, and death records. The survey collected data on hope, measured generally by the Herth Hope Index (HHI) and more narrowly by two questions on illness-related hope. Generalized linear regression and Cox models were used to test our hypotheses. RESULTS: 142 (78%) survey participants died during the period of analysis, with close to half (46%) doing so within a year of the survey. Contrary to expectation, HHI scores did not have a significant association with healthcare utilization, expenditure or survival. Yet, illness-related hope, defined as those who expected to live at least 2 years, as opposed to the likely prognosis of 1 year or less as determined by the primary treating oncologist, had 6.6 more planned hospital encounters (95% CI 0.90 to 12.30) in the 12-months following the survey and 41% lower mortality risk (hazard ratio: 0.59, 95% CI 0.36 to 0.99) compared to those who were less optimistic. Secondary analysis among decedents showed that patients who believed that the primary intent of their treatment is curative, had higher total expenditure (S$30,712; 95% CI S$3,143 to S$58,282) in the last 12 months of life than those who did not have this belief. CONCLUSION: We find no evidence of a relationship between a general measure of hope and healthcare utilization, expenditure, or survival among advanced cancer patients. However, greater illness-related hope is positively associated with these outcomes. Frontiers Media S.A. 2023-05-23 /pmc/articles/PMC10242009/ /pubmed/37287770 http://dx.doi.org/10.3389/fpsyg.2023.1151976 Text en Copyright © 2023 Chay, Huynh, Cheung, Kanesvaran, Lee, Malhotra and Finkelstein. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychology Chay, Junxing Huynh, Vinh Anh Cheung, Yin Bun Kanesvaran, Ravindran Lee, Lai Heng Malhotra, Chetna Finkelstein, Eric Andrew The relationship between hope, medical expenditure and survival among advanced cancer patients |
title | The relationship between hope, medical expenditure and survival among advanced cancer patients |
title_full | The relationship between hope, medical expenditure and survival among advanced cancer patients |
title_fullStr | The relationship between hope, medical expenditure and survival among advanced cancer patients |
title_full_unstemmed | The relationship between hope, medical expenditure and survival among advanced cancer patients |
title_short | The relationship between hope, medical expenditure and survival among advanced cancer patients |
title_sort | relationship between hope, medical expenditure and survival among advanced cancer patients |
topic | Psychology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242009/ https://www.ncbi.nlm.nih.gov/pubmed/37287770 http://dx.doi.org/10.3389/fpsyg.2023.1151976 |
work_keys_str_mv | AT chayjunxing therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT huynhvinhanh therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT cheungyinbun therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT kanesvaranravindran therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT leelaiheng therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT malhotrachetna therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT finkelsteinericandrew therelationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT chayjunxing relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT huynhvinhanh relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT cheungyinbun relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT kanesvaranravindran relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT leelaiheng relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT malhotrachetna relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients AT finkelsteinericandrew relationshipbetweenhopemedicalexpenditureandsurvivalamongadvancedcancerpatients |